{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9741302", "DateCompleted": {"Year": "1998", "Month": "10", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0032-0943", "JournalIssue": {"Volume": "64", "Issue": "6", "PubDate": {"Year": "1998", "Month": "Aug"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Vitexicarpin, a flavonoid from the fruits of Vitex rotundifolia, inhibits mouse lymphocyte proliferation and growth of cell lines in vitro.", "Pagination": {"StartPage": "546", "EndPage": "550", "MedlinePgn": "546-50"}, "Abstract": {"AbstractText": ["Certain flavonoids having a C-2,3-double bond were reported to show an inhibitory activity against T-lymphocyte proliferation, but not against B-lymphocyte proliferation in vitro. In the course of these studies, vitexicarpin (3',5-dihydroxy-3,4',6,7-tetramethoxyflavone) isolated from the fruits of Vitex rotundifolia was found to show potent inhibition against lymphocyte proliferation. Vitexicarpin inhibited T-lymphocyte proliferation as well as B-lymphocyte proliferation at > 0.1 microM. IC50's were approximately 0.7 microM both for T- and B-cell proliferation. The inhibitory activity of vitexicarpin was reversible. Vitexicarpin also inhibited the growth of certain cancer cell lines, EL-4 and P815.9 (IC50 = 0.25-0.3 microM). These results suggest that vitexicarpin may be a potential therapeutic agent involved in inflammatory/immunoregulatory disorders such as rheumatoid arthritis and lymphomas."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Kangwon National University, Chunchon, Korea."}], "LastName": "You", "ForeName": "K M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Son", "ForeName": "K H", "Initials": "KH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Chang", "ForeName": "H W", "Initials": "HW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kang", "ForeName": "S S", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kim", "ForeName": "H P", "Initials": "HP"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "753GT729OU", "NameOfSubstance": "casticin"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["cytology", "drug effects", "immunology"], "DescriptorName": "B-Lymphocytes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Chamomile"}, {"QualifierName": ["chemistry", "pharmacology", "toxicity"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "L Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lymphocyte Activation"}, {"QualifierName": [], "DescriptorName": "Lymphoma"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mast-Cell Sarcoma"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["toxicity"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["toxicity"], "DescriptorName": "Quercetin"}, {"QualifierName": ["immunology"], "DescriptorName": "Spleen"}, {"QualifierName": ["cytology", "drug effects", "immunology"], "DescriptorName": "T-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "9", "Day": "19"}, {"Year": "1998", "Month": "9", "Day": "19", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "9", "Day": "19", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9741302", "10.1055/s-2006-957511"]}}]}